Predictive Technology Group Acquires ReNovo Biotech
Predictive Technology Group has finalized its acquisition of ReNovo Biotech, which will now be called Predictive Biotech, the Salt Lake City, Utah-based company announced Tuesday.
PRED will gain access to ReNovo’s cellular, tissue, biomaterial and regenerative products and candidates, in addiction to distribution channels.
Under the agreement, ReNovo’s CEO Eric Olson will serve as president of the newly named subsidiary.
The buy advances PRED’s expansion strategy of acquiring complementary diagnostic and therapeutic companies. Financial terms were not disclosed. — Anisa Jibrell